Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$9.64K Buy
550
+176
+47% +$3.4K ﹤0.01% 4351
2026
Q1
$7.87K Sell
374
-1,336
-78% -$30.2K ﹤0.01% 2575
2025
Q4
$37.2K Buy
1,710
+1,387
+429% +$28.5K ﹤0.01% 1770
2025
Q3
$6.05K Buy
323
+174
+117% +$3.74K ﹤0.01% 2808
2025
Q2
$3.24K Buy
+149
New +$3.36K ﹤0.01% 2397

Other funds holding PHI

Arax Advisory Partners's PHI Position: Q2 2026 in Review

Arax Advisory Partners increased its PLDT (PHI) stake by 47% in Q2 2026, buying an estimated $3.4K and bringing the position to 550 shares worth $9.64K. The position accounts for ﹤0.01% of the portfolio, ranked #4351.

Arax Advisory Partners first reported a position in PHI in Q2 2025 and has held it in 5 quarters since. The position peaked at $37.2K in Q4 2025. 100 funds tracked by Wall St. Rank hold PHI as of Q2 2026.

  • Arax Advisory Partners held 550 shares of PLDT worth $9.64K as of Q2 2026.
  • Arax Advisory Partners bought 176 PLDT shares in Q2 2026, an estimated $3.4K.
  • PLDT made up ﹤0.01% of Arax Advisory Partners's portfolio in Q2 2026, its #4351 holding.
  • Arax Advisory Partners first reported a position in PLDT in Q2 2025 and has held it in 5 quarters since.
  • Arax Advisory Partners's PLDT position peaked at $37.2K in Q4 2025.
  • 100 funds tracked by Wall St. Rank held PLDT as of Q2 2026.

Based on Arax Advisory Partners's 13F filing for Q2 2026, filed 10 Aug 2026.